University of Washington School of Public Health
Post-doctoral fellow - The Wistar Institute
Closing Date: January 12, 2018
Posted: November 20, 2017
The Wistar Institute Vaccine & Immunotherapy Center and The Wistar Institute Cancer Center comprise a group of 35 exceptional faculty dedicated to fundamental and translational research in cancer biology, immunology, virology and genetics. Fellows will be provided their own research space, resources and support needed to run their own labs and pursue their own independent research agenda. Fellows will be appointed for a three-year term with the possibility of extending an additional one to two years. Two Fellows will be recruited in 2018: one Fellow with a cancer focus that will join Wistar’s NCI-designated Cancer Center and one with a vaccine/immunology focus that will join Wistar’s Vaccine & Immunotherapy Center.Skills/Eligibility:
Program candidates must demonstrate intellectual drive and superior research credentials, a particularly creative and innovative research plan, strong communication skills, and the motivation and demonstrated capacity to conduct research with minimal supervision. Candidates whose work is based on biological principles, but incorporates concepts from diverse fields, are encouraged to apply. Candidates must hold a Ph.D., M.D., or equivalent degree. Candidates are expected to have a strong publication record.How to Apply:
The search committees will be led by Wistar program leaders who are ideally suited to recognize how well a prospective candidate fits within the overall Wistar mission, and its specific programs. Interested candidates should electronically submit a cover letter, curriculum vitae, a description of previous research (one page), a concise statement of research plans (up to two pages), reprints of four publications and the names of three references to the attention of Maria Colelli, Search Coordinator Caspar Wistar Fellows Program (firstname.lastname@example.org). Please see our ads online in Nature and Science magazines. Applications will be evaluated by January 29, 2018. Interviews will be held beginning in April 2018.